Iñigo Anduaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Iñigo Anduaga has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Affronti
Cardiovascular Surgery, Hospital Clínic, University of Barcelona, Spain
1 shared publication - Ander Regueiro
Cardiovascular Institute, Hospital Clinic, Institut D’investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain
1 shared publication - Eduard Quintana
Department of Cardiovascular Surgery, Departament de Cirurgia I EspecialitatsMedicoquirúrgiques, Facultat de Medicina I Ciències de La Salut, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
1 shared publication - Eduardo Flores-Umanzor
Cardiology Department, Institut Clínic Cardiovascular, Hospital Clinic de Barcelona, 08036 Barcelona, Spain
1 shared publication - Jorge Alcocer
University of Barcelona
1 shared publication - Laura Sanchis
Department of Cardiology, Cardiovascular Institute Hospital Clínic Barcelona Spain
1 shared publication
Latest Publications
- Open Access
- 25 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5524
Non-Pharmacological Stroke Prevention in Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia worldwide. It is associated with increased mortality and morbidity, especially due to the increased risk of ischemic stroke and systemic embolism in these patients. For this reason, thromboembolism prevention is the cornerstone of managing AF, and oral anticoagulation is nowadays the first-line treatment. However, since most thrombi form in the left atrial appendage and anticoagulant therapy may have side effects and be contraindicated in some patients, surgical and percutaneous left atrial appendage occlusion (LAAO) have emerged as a non-pharmacological alternative. This review summarizes all existing evidence on surgical and percutaneous LAAO.
- 25 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5524
Open AccessNon-Pharmacological Stroke Prevention in Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia worldwide. It is associated with increased mortality and morbidity, especially due to the increased risk of ischemic stroke and systemic embolism in these patients. For this reason, thromboembolism prevention is the cornerstone of managing AF, and oral anticoagulation is nowadays the first-line treatment. However, since most thrombi form in the left atrial appendage and anticoagulant therapy may have side effects and be contraindicated in some patients, surgical and percutaneous left atrial appendage occlusion (LAAO) have emerged as a non-pharmacological alternative. This review summarizes all existing evidence on surgical and percutaneous LAAO.